Viral load suppression at 12 months
A total of 347/390 (89%) participants were followed up for 12 months. Of the 43 participants who were not tested at 12 months, 24 (56%) were lost to follow up, 14 (32%) transferred to other programs and 5 (12%) died. Among participants with 12-month virologic outcomes, 114 (80%) in the clinic-based SAMBA assay arm were suppressed compared to 135 (81%) in the SOC arm (